+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Otorhinolaryngology Devices Market by Product Type and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5019917
  • Report
  • February 2020
  • Region: Global
  • 207 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Atos Medical AB
  • Cochlear Ltd.
  • Hill-Rom Holdings Inc.
  • Medtronic Plc.
  • Olympus Corporation
  • Sonova Group
The global otorhinolaryngology devices market was valued at $9,268 million in 2018, and is projected to reach $13,999 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.Otorhinolaryngology devices are used to treat and diagnose disorders related to ear, nose, and throat, such as smelling disorders, hearing disorders as well as problems associated with speaking or snoring. It includes several diagnostics and surgical products such as endoscopes, powered surgical instruments, handheld surgical instruments, balloon sinus dilation devices, hearing screening devices, hearing aids, hearing implants, CO2 lasers, image-guided surgery systems, ear tubes, nasal and otological devices. These otorhinolaryngology devices assist otolaryngologists for the treatment of patients suffering from disorders of ear, nose, throat, and related structures of the head & neck.



The global otorhinolaryngologydevices market is anticipated to experience significant growth during the forecast period due to technological advancements and rise in prevalence rate of diseases that require otorhinolaryngology devices. In addition, favorable FDA approvals & reimbursement policies in developed economies, surge in patient preference for minimally invasive surgeries, and shorter recovery time & minimal postoperative complications further drive the growth of the global otorhinolaryngology devices market. However, high cost of otorhinolaryngology instruments and procedure and stringent government regulations hinder the growth of the market globally. On the contrary, various growth opportunities from emerging economies are anticipated to provide lucrative opportunities for the otorhinolaryngology devices market growth.

The global otorhinolaryngology devices market is segmented on the basis of product, end user, and region. By product, the market is bifurcated into diagnostic devices, surgical devices, hearing aids, image-guided surgery systems, and others. By end user, the market is segmented into hospitals, ENT clinics, and others. Regionwise, the otorhinolaryngology devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS
  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2026, which assist to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global otorhinolaryngology devices market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Product
  • Diagnostic Devices
  • Surgical Devices
  • Hearing Aids
  • Image-guided Surgery Systems
  • Others

By End User
  • Hospitals
  • ENT Clinics
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Spain
  • Italy
  • UK
  • Rest of Europe
  • Asia-Pacific
  • Australia
  • Japan
  • India
  • China
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Atos Medical AB
  • Cochlear Ltd.
  • Freudenberg SE (InHealth Technologies, Inc.)
  • Hill-Rom Holdings, Inc.
  • Johnson & Johnson (Acclarent, Inc.)
  • Medtronic Plc.
  • Olympus Corporation
  • Sonova Group
  • Starkey Hearing Technologies
  • Stryker Corporation

The other players in the value chain (profiles not included in the report)
  • Smith & Nephew plc
  • Hoya Corporation
  • William Demant Holdings A/S
  • Stema Medizin
  • Siemens Healthcare
Frequently Asked Questions about the Global Otorhinolaryngology Devices Market

What is the estimated value of the Global Otorhinolaryngology Devices Market?

The Global Otorhinolaryngology Devices Market was estimated to be valued at $9268.0 million in 2018.

What is the growth rate of the Global Otorhinolaryngology Devices Market?

The growth rate of the Global Otorhinolaryngology Devices Market is 5.3%, with an estimated value of $13999.0 million by 2026.

What is the forecasted size of the Global Otorhinolaryngology Devices Market?

The Global Otorhinolaryngology Devices Market is estimated to be worth $13999.0 million by 2026.

Who are the key companies in the Global Otorhinolaryngology Devices Market?

Key companies in the Global Otorhinolaryngology Devices Market include Atos Medical AB, Cochlear Ltd., Freudenberg SE (InHealth Technologies Inc.), Hill, Rom Holdings Inc., Johnson & Johnson (Acclarent Inc.), Medtronic Plc., Olympus Corporation and Starkey Hearing Technologies.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Atos Medical AB
  • Cochlear Ltd.
  • Hill-Rom Holdings Inc.
  • Medtronic Plc.
  • Olympus Corporation
  • Sonova Group

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter's five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. High prevalence of chronic sinusitis
3.4.1.2. Rise in adoption of minimally invasive ENT procedures
3.4.1.3. Rapid growth in the elderly population
3.4.2. Restraints
3.4.2.1. Limited awareness and high costs
3.4.2.2. Government regulations and reimbursement issues
3.4.3. Opportunity
3.4.3.1. High growth prospects in emerging markets
CHAPTER 4: OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Diagnostic Devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Surgical Devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Hearing Aids
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Image-guided Surgery Systems
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Others
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
CHAPTER 5: GLOBAL OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. ENT Clinics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: OTORHINOLARYNGOLOGY DEVICES CAMERA MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America otorhinolaryngology devices market, by country
6.2.2.1. U.S. otorhinolaryngology devices market, by product
6.2.2.2. U.S. otorhinolaryngology devices market, by end user
6.2.2.3. Canada otorhinolaryngology devices market, by product
6.2.2.4. Canada otorhinolaryngology devices market, by end user
6.2.2.5. Mexico otorhinolaryngology devices market, by product
6.2.2.6. Mexico otorhinolaryngology devices market, by end user
6.2.3. North America otorhinolaryngology devices market, by product
6.2.4. North America otorhinolaryngology devices market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe otorhinolaryngology devices market, by country
6.3.2.1. Germany otorhinolaryngology devices market, by product
6.3.2.2. Germany otorhinolaryngology devices market, by end user
6.3.2.3. France otorhinolaryngology devices market, by product
6.3.2.4. France otorhinolaryngology devices market, by end user
6.3.2.5. UK otorhinolaryngology devices market, by product
6.3.2.6. UK otorhinolaryngology devices market, by end user
6.3.2.7. Italy otorhinolaryngology devices market, by product
6.3.2.8. Italy otorhinolaryngology devices market, by end user
6.3.2.9. Spain otorhinolaryngology devices market, by product
6.3.2.10. Spain otorhinolaryngology devices market, by end user
6.3.2.11. Rest of Europe otorhinolaryngology devices market, by product
6.3.2.12. Rest of Europe otorhinolaryngology devices market, by end user
6.3.3. Europe otorhinolaryngology devices market, by product
6.3.4. Europe otorhinolaryngology devices market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific otorhinolaryngology devices market, by country
6.4.2.1. Japan otorhinolaryngology devices market, by product
6.4.2.2. Japan otorhinolaryngology devices market, by end user
6.4.2.3. China otorhinolaryngology devices market, by product
6.4.2.4. China otorhinolaryngology devices market, by end user
6.4.2.5. Australia otorhinolaryngology devices market, by product
6.4.2.6. Australia otorhinolaryngology devices market, by end user
6.4.2.7. India otorhinolaryngology devices market, by product
6.4.2.8. India otorhinolaryngology devices market, by end user
6.4.2.9. South Korea otorhinolaryngology devices market, by product
6.4.2.10. South Korea otorhinolaryngology devices market, by end user
6.4.2.11. Rest of Asia-Pacific otorhinolaryngology devices market, by product
6.4.2.12. Rest of Asia-Pacific otorhinolaryngology devices market, by end user
6.4.3. Asia-Pacific otorhinolaryngology devices market, by product
6.4.4. Asia-Pacific otorhinolaryngology devices market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA otorhinolaryngology devices market, by country
6.5.2.1. Brazil otorhinolaryngology devices market, by product
6.5.2.2. Brazil otorhinolaryngology devices market, by end user
6.5.2.3. Saudi Arabia otorhinolaryngology devices market, by product
6.5.2.4. Saudi Arabia otorhinolaryngology devices market, by end user
6.5.2.5. South Africa otorhinolaryngology devices market, by product
6.5.2.6. South Africa otorhinolaryngology devices market, by end user
6.5.2.7. Rest of LAMEA otorhinolaryngology devices market, by product
6.5.2.8. Rest of LAMEA otorhinolaryngology devices market, by end user
6.5.3. LAMEA otorhinolaryngology devices market, by product
6.5.4. LAMEA otorhinolaryngology devices market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Atos Medical AB
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Cochlear Ltd.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Freudenberg SE (InHealth Technologies, Inc.)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. HILL-ROM HOLDINGS, INC.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Johnson & Johnson (Acclarent, Inc.)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Medtronic Plc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Olympus Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Sonova Group
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Starkey Hearing Technologies
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Stryker Corporation
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Atos Medical AB
  • Cochlear Ltd.
  • Hill-Rom Holdings Inc.
  • Medtronic Plc.
  • Olympus Corporation
  • Sonova Group
According to the report titled 'Global Otorhinolaryngology Devices Market by Product, End User, and Region: Opportunity Analysis and Industry Forecast, 2018-2026,' the global otorhinolaryngology devices market was valued at $9.26billion in 2018, and is projected to reach $13.99billion by 2026, at a CAGR of 5.2% from 2019 to 2026.The diagnostic devices segment garnered more than one-third of the total otorhinolaryngology devices market share in 2018.

Otorhinolaryngology devices are the instruments used for the diagnosis and treatment of various ear, nose, and throat disorders. These devices witnessed significant increase in the demand due to rise in number of geriatric populations especially in developing countries and increase in funding by the government and private companies in the R&D activities of advanced and novel otorhinolaryngology diagnostic and surgical devices. In addition, increase in the ENT disorder such as tonsillitis, ear infections, sinus infections, and sleep apnea further propels the growth of the global otorhinolaryngology devices market. However, high cost of ENT instruments & procedure and stringent government regulations are expected to hinder the growth of the market globally. On the contrary, various growth opportunities from emerging economies and medical tourism are anticipated to provide lucrative opportunities for the market players of the otorhinolaryngology devices market.

Capsule endoscopy emerged to be a highly preferred technology due to its minimally invasive nature and is designated as a breakthrough in otorhinolaryngology device technology to diagnose various diseases. Despite numerous advancements in the otorhinolaryngology devices field, the flexible endoscopes segment is expected to maintain its lead in the global market due to its high precision, sensitivity, specificity, and safety as compared to other at economical cost. The hearing aids segment is expected to grow at the fastest rate of 7.6% during the analysis period, owing to surge in prevalence of diseases related to ear and increase in number of hearing loss due to genetic problem or accident.

By end user, the ENT clinics segment is expected to maintain its lead in the overall otorhinolaryngology devices market due to the availability of diverse otorhinolaryngology services and favorable reimbursement policies. Most ENT clinics are well-equipped with technologically advanced facilities mainly in developed economies. However, low awareness, lack of skilled professionals, and unmet medical needs at economical cost hamper the market growth in developing economies. The otorhinolaryngology devices market has witnessed significant growth in North America and Europe due to high prevalence rate of ENT disorder, increase in geriatric population, and well-established healthcare infrastructure.

According to Onkar Sumant, Assistant Manager, Healthcare, “The growth of the global otorhinolaryngology devices market is majorly attributable to rise in prevalence of ear, nose, and throat diseases. In addition, increase in adoption of innovative otorhinolaryngology devices such as capsule endoscopes and robot-assisted otorhinolaryngology surgery along with ultra-high-definition visualization systems is anticipated to boost the market growth in the coming years.

The major players operating in the otorhinolaryngology devices market include Atos Medical AB, Cochlear Ltd., Freudenberg SE (InHealth Technologies, Inc.), Hill-Rom Holdings, Inc., Johnson & Johnson (Acclarent, Inc.), Medtronic Plc., Olympus Corporation, Sonova Group, Starkey Hearing Technologies, and Stryker Corporation.

Other key players (not included in the report) include Smith & Nephew plc, Hoya Corporation, William Demant Holdings A/S, Stema Medizin, Siemens Healthcare, and among others.

KEY FINDINGS OF THE STUDY
  • Based on product, the surgical devices segment was the second major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period.
  • Depending on end user, the others end user segment is expected to exhibit the highest CAGR with 5.5% during the forecast period.
  • By region, North America was the largest revenue contributor in 2018, and is expected to continue this trend from 2019 to 2028.
  • U.S. generated the highest revenue in the global otorhinolaryngology devices market in 2018, accounting for more than one-third of the global market in 2018.
  • Asia-Pacific is anticipated to grow at a highest CAGR during the forecast period.
Note: Product cover images may vary from those shown
  • Atos Medical AB
  • Cochlear Ltd.
  • Freudenberg SE (InHealth Technologies Inc.)
  • Hill-Rom Holdings Inc.
  • Johnson & Johnson (Acclarent Inc.)
  • Medtronic Plc.
  • Olympus Corporation
  • Sonova Group
  • Starkey Hearing Technologies
  • Stryker Corporation.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...